Literature DB >> 16489101

Pioglitazone prevents cardiac remodeling in high-fat, high-calorie-induced Type 2 diabetes mellitus.

Walter E Rodriguez1, Irving G Joshua, Jeff C Falcone, Suresh C Tyagi.   

Abstract

The agonists of peroxisome proliferator-activated receptor-gamma (PPARgamma) ameliorate cardiovascular complications associated with diabetes mellitus. We tested the hypothesis that recovery from ailing to failing myocardium in diabetes by PPARgamma agonist is in part due to decreased matrix metalloproteinase-9 (MMP-9) activation and left ventricular (LV) tissue levels of homocysteine (Hcy). C57BL/6J mice were made diabetic (D) by feeding them a high-fat calorie diet. PPARgamma was activated by adding pioglitazone (Pi) to the diet. After 6 wk, mice were grouped into: normal calorie diet (N), D, N + Pi and D + Pi (n = 6 in each group). LV variables were measured by echocardiography, endothelial-myocyte (E-M) coupling was measured in cardiac rings, and MMP-9 activation was measured by zymography. Blood glucose levels were twofold higher in D mice compared with N mice. Pi decreased the levels of glucose in D mice to the levels in N mice. LV Hcy levels were 3.5 +/- 0.5 microM in N groups compared with 12.4 +/- 0.6 microM in D groups. Treatment with Pi normalized the LV levels of Hcy but had no effect on plasma levels of Hcy. In the D group, LV contraction was reduced compared with that of the N group and was ameliorated by treatment with Pi. LV wall thickness was reduced to 0.25 +/- 0.02 mm in the D group compared with 0.42 +/- 0.01 mm in the N group. LV diastolic diameter was 3.05 +/- 0.01 mm in the D group compared with 2.20 +/- 0.02 mm in the N group. LV systolic diameter was 1.19 +/- 0.02 mm in the D group and 0.59 +/- 0.01 mm in the N group. Pi normalized the LV variables in D mice. The responses to ACh and nitroprusside were attenuated in diabetic hearts, suggesting that there was E-M uncoupling in the D group compared with the N group, which was ameliorated by Pi. Plasma and LV levels of MMP-2 and -9 activities were higher in the D group than in the N group but normalized after Pi treatment. These results suggest that E-M uncoupling in the myocardium, in part, is due to increased MMP activities secondary to suppressing PPARgamma activity in high-fat, calorie-induced Type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16489101     DOI: 10.1152/ajpheart.01331.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  Uncoupling protein-2 expression and effects on mitochondrial membrane potential and oxidant stress in heart tissue.

Authors:  Jesús A Cabrera; Elizabeth A Ziemba; Robert Colbert; Rosemary F Kelly; Michael Kuskowski; Edgar A Arriaga; Wim Sluiter; Dirk J Duncker; Herbert B Ward; Edward O McFalls
Journal:  Transl Res       Date:  2011-12-02       Impact factor: 7.012

2.  Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis.

Authors:  Xue Lin; Penghua Yang; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2017-04-13       Impact factor: 8.661

3.  Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

Authors:  Utpal Sen; Suresh C Tyagi
Journal:  PPAR Res       Date:  2010-06-29       Impact factor: 4.964

Review 4.  Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance.

Authors:  Evangelos Oikonomou; Konstantinos Mourouzis; Petros Fountoulakis; Georgios Angelos Papamikroulis; Gerasimos Siasos; Alexis Antonopoulos; Georgia Vogiatzi; Sotiris Tsalamadris; Manolis Vavuranakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

Review 5.  Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.

Authors:  Lorenzo Nesti; Domenico Tricò; Alessandro Mengozzi; Andrea Natali
Journal:  Cardiovasc Diabetol       Date:  2021-05-18       Impact factor: 9.951

6.  Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.

Authors:  Carmen Mingorance; Lucie Duluc; Matthieu Chalopin; Gilles Simard; Pierre-Henri Ducluzeau; Maria Dolores Herrera; Maria Alvarez de Sotomayor; Ramaroson Andriantsitohaina
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

7.  Protective effect of pioglitazone on cardiomyocyte apoptosis in low-dose streptozotocin & high-fat diet-induced type-2 diabetes in rats.

Authors:  Uma Bhandari; Vinay Kumar; Parveen Kumar; C D Tripathi; Geetika Khanna
Journal:  Indian J Med Res       Date:  2015-11       Impact factor: 2.375

8.  MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion.

Authors:  Tong Zou; Mei Zhu; Yi-Cheng Ma; Fei Xiao; Xue Yu; Li Xu; Lan-Qing Ma; Jiefu Yang; Jian-Zeng Dong
Journal:  Sci Rep       Date:  2018-06-08       Impact factor: 4.379

9.  Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice.

Authors:  Bong-Hoi Choi; Zhen Jin; Chin-Ok Yi; Juhong Oh; Eun Ae Jeong; Jong Youl Lee; Kyung-Ah Park; Kyung Eun Kim; Jung Eun Lee; Hyun-Jin Kim; Jong Ryeal Hahm; Gu Seob Roh
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

10.  Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats.

Authors:  Eileen R Blasi; Jonathan Heyen; Michelle Hemkens; Aileen McHarg; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  PPAR Res       Date:  2009-06-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.